DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

JUNE 13, 2024

Goar, MD, medical director at the Norma Melchor Heart & Vascular Institute , was distinguished with the Andreas Grüntzig Ethica Award , the highest global honor in interventional cardiology. Andreas Grüntzig was a pioneer in the field, so I’m grateful and honored to receive the Ethica Award,” said Dr. St.

Cardiothoracic 104

Cardiothoracic Interventional Cardiology Bicuspid/Mitral Innovation 104

ADN Center of Excellence

DECEMBER 4, 2023

The realm of mitral valve disease management is witnessing an unprecedented surge of advancements. The Evolution of Treatment Modalities Historically, surgical repair has stood as the cornerstone in addressing primary mitral regurgitation. Addressing calcification-induced stenosis and regurgitation necessitates innovative solutions.

Bicuspid/Mitral 52

Bicuspid/Mitral Innovation Interventional Cardiology Stenosis 52

ADN Center of Excellence

MARCH 18, 2024

In the dynamic realm of interventional cardiology, education is the cornerstone of excellence. ADN CoE recently hosted a groundbreaking Mitral & Tricuspid Valve Interventions Training, uniting cardiologists from around the globe for an immersive learning experience.

Tricuspid 52

Tricuspid Bicuspid/Mitral Interventional Cardiology Education 52

DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

ADN Center of Excellence

DECEMBER 4, 2023

The realm of mitral valve disease management is witnessing an unprecedented surge of advancements. The Evolution of Treatment Modalities Historically, surgical repair has stood as the cornerstone in addressing primary mitral regurgitation. Addressing calcification-induced stenosis and regurgitation necessitates innovative solutions.

Bicuspid/Mitral 40

Bicuspid/Mitral Innovation Interventional Cardiology Stenosis 40

DAIC

FEBRUARY 9, 2024

Photo by Cedars-Sinai Raj Makkar, MD , associate director of the Smidt Heart Institute and vice president of Cardiovascular Innovation and Intervention for Cedars-Sinai, was the principal investigator for the TRISCEND II trial at Cedars-Sinai. Corday, MD, Chair in Interventional Cardiology. “It Raj Makkar, MD.

Tricuspid 105

Tricuspid Open-Heart Surgery Interventional Cardiology Bicuspid/Mitral 105